Journey Medical annual ebitda
2020
2021
Journey Medical EBITDA Growth & History (DERM)
Journey Medical's calculated EBITDA was −$34.9M for fiscal 2021.
View full Journey Medical company overviewJourney Medical annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2021 | 2021-12-31 | −$34.9M | −$42.7M | — |
| 2020 | 2020-12-31 | $7.9M | — | — |
Journey Medical quarterly ebitda
Q3.20
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q3 2020 | 2020-09-30 | $640,000 | — | — |
Journey Medical ebitda trends
Across the available reported history, Journey Medical's ebitda decreased from $7.9M to −$34.9M, a change of −$42.7M. The latest reported quarter, Q3 2020, shows $640,000.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Journey Medical filings at SEC.gov ↗